FJPTX | FPJAX | FJPTX / FPJAX | |
Total Expense Ratio | 1.20 | 0.95 | 126% |
Annual Report Gross Expense Ratio | 1.20 | 0.95 | 126% |
Fund Existence | 15 years | 15 years | - |
Gain YTD | 17.712 | 17.899 | 99% |
Front Load | 4% | 6% | 61% |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 763M | 763M | 100% |
Annual Yield % from dividends | 1.88 | 2.00 | 94% |
Returns for 1 year | 18.34 | 18.69 | 98% |
Returns for 3 years | 42.02 | 43.19 | 97% |
Returns for 5 years | 27.78 | 29.69 | 94% |
Returns for 10 years | 65.01 | 68.19 | 95% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LIRRX | 9.53 | 0.07 | +0.74% |
Lord Abbett International Value R3 | |||
NSFDX | 8.99 | 0.01 | +0.11% |
Natixis Target Retirement 2020 N | |||
AASOX | 16.95 | -0.01 | -0.06% |
Alger Small Cap Growth I-2 | |||
ASVYX | 9.84 | -0.02 | -0.20% |
American Century Small Cap Value Y | |||
FIJYX | 28.77 | -0.21 | -0.72% |
Fidelity Advisor Biotechnology Z |